BioCommerce Week’s Index to the Diversified Molecular Biology Tools Companies

On a week when Merck withdrew its anti-inflammatory medicine Vioxx from the market, the BioCommerce Week Index of Diversified Molecular Biology Tools Companies recovered from last week’s 3-percent fall, registering a 2-percent gain for the weekly period ending Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.